IL37 and inflammatory bowel disease: The effect of LYCO on interleukin-23 (IL-23), another mediator of inflammation in colon tissues, is presented in Figure 7B. In the control group before IBD, IL-23 level (no IBD, no LYCO) was 13.19 ± 1.9 pg/mg of protein.